Corvus reports Q3 2026 results, outlines soquelitinib pipeline milestones for 2027Nov 5Quarterly updateCorvus Pharmaceuticals, Inc.soquelitinib
Corvus registers Phase 1b trial of soquelitinib in hidradenitis suppurativaSep 18Trial updateCorvus Pharmaceuticals, Inc.soquelitinib
Aclaris reports Q2 2026 results, ATI-052 Phase 1a data and reaffirmed timelinesAug 6Quarterly updateAclaris Therapeutics, Inc.
Corvus reports Q2 2026 results, updates soquelitinib pipeline progressAug 6Quarterly updateCorvus Pharmaceuticals, Inc.soquelitinib